Medicare and Medicaid
Oncologists Call for Medicare to Reconsider Anemia Drug Restrictions
Published in Aging and Elder Health Week, December 2nd, 2007
The Community Oncology Alliance (COA), representing community cancer centers nationwide, formally requested that the Centers for Medicare & Medicaid Services (CMS) reconsider its decision to restrict the access of senior cancer patients to vital anemia-fighting drugs. Effective July 30, 2007, CMS implemented a National Coverage Determination (NCD) limiting oncologists' use of anemia-fighting drugs, referred to as Erythopoiesis Stimulating Agents (ESAs) in Medicare cancer patients undergoing chemotherapy treatment. Anemia is a common side effect of chemotherapy, and ESAs are used to minimize the need for red blood cell transfusions.
According to Dr. Patrick Cobb, a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging and Elder Health Week
More Articles from Aging and Elder Health Week
- Aging
New Research Shows Sharp Rise in Nursing Home Care Violations Under Private Equity Ownership - Alzheimer Disease
An Alzheimer's vaccine? - Alzheimer Disease
Research from N.G. Castle and co-researchers in the area of Alzheimer disease described - Alzheimer Disease
The CNS Market Outlook to 2012 is a New Report That Provides a Detailed Epidemiological Analysis of Major Indications Within the CNS Disorders Market - Alzheimer Disease Therapy
Reports summarize Alzheimer disease therapy study results from Cornell University - American Medical Association
AMA Honors Idaho Medical Association Executive - More from this issue of Aging and Elder Health Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
